Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is now a range of genome- and epigenome-editing techniques (reviewed by Pamies et al., 2018), as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concept of Good Cell Culture Practice (GCCP) (Coecke et al., 2005) was developed and gradually adapted to ongoing scientific progress (Pamies et al., 2018) as a guidance document for in vitro reporting standards.”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“GCCP 2.0 is trying to complement these for stem cell-derived models and microphysiological systems (MPS).”
From Toward good in vitro reporting standards (2019) · cites this paper as Pamies et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Complementarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Pamies et al. 2018
The cited source says what the claim attributes to it.
In the citing paper
“This is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known (Pamies et al., 2018).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct
Pereira, R., Martin, M., Roussel, A., Carribault, P., & Gautier, T. (2023) · Lecture Notes in Computer Science · doi:10.1007/978-3-031-40744-4_5 · Cited by 12,935
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Long non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Modeling physiological events in 2D vs. 3D cell culture
Duval, K., Grover, H., Han, L.-H., Mou, Y., Pegoraro, A. F., Fredberg, J., & Chen, Z. (2017) · Physiology · doi:10.1152/physiol.00036.2016 · Cited by 1,849
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
Chapman, J. R., Taylor, M. R. G., & Boulton, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.029 · Cited by 1,625
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., et al. (2013) · Science · doi:10.1126/science.1239278 · Cited by 1,402
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336
3D Cell Culture Systems: Advantages and Applications
Ravi, M., Paramesh, V., Kaviya, S. R., Anuradha, E., & Solomon, F. D. P. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24683 · Cited by 1,206
Wang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3545 · Cited by 837
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Gene targeting using zinc finger nucleases
Porteus, M. H., & Carroll, D. (2005) · Nature Biotechnology · doi:10.1038/nbt1125 · Cited by 641
Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 598
Pluripotent stem cells in disease modelling and drug discovery
Avior, Y., Sagi, I., & Benvenisty, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.27 · Cited by 592
Advances in the formation, use and understanding of multi-cellular spheroids
Achilli, T.-M., Meyer, J., & Morgan, J. R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.707181 · Cited by 572
Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells.
Rouet, P., Smih, F., & Jasin, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6064 · Cited by 570
3D Cell Culture: A Review of Current Approaches and Techniques
Haycock, J. W. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-984-0_1 · Cited by 534
Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro
Knight, E., & Przyborski, S. (2015) · Journal of Anatomy · doi:10.1111/joa.12257 · Cited by 530
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Methods for making induced pluripotent stem cells: reprogramming à la carte
González, F., Boué, S., & Belmonte, J. C. I. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2937 · Cited by 508
González, F., Zhu, Z., Shi, Z.-D., Lelli, K., Verma, N., Li, Q. V., & Huangfu, D. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.05.018 · Cited by 503
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., Kuperwasser, N., Motola, D. L., Meissner, T. B., Hendriks, W. T., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.011 · Cited by 501
Microfluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
Fetal Bovine Serum (FBS): past ‐ present ‐ future
van der Valk, J. (2018) · ALTEX · doi:10.14573/altex.1705101 · Cited by 481
Veres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474
Choulika, A., Perrin, A., Dujon, B., & Nicolas, J.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1968 · Cited by 460
Ding, Q., Regan, S. N., Xia, Y., Oostrom, L. A., Cowan, C. A., & Musunuru, K. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.006 · Cited by 459
Small molecules enhance CRISPR genome editing in pluripotent stem cells
Yu, C., Liu, Y., Ma, T., Liu, K., Xu, S., Zhang, Y., Liu, H., La Russa, M., Xie, M., Ding, S., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.003 · Cited by 455
A bioinformatic assay for pluripotency in human cells
Müller, F.-J., Schuldt, B. M., Williams, R., Mason, D., Altun, G., Papapetrou, E. P., Danner, S., Goldmann, J. E., Herbst, A., Schmidt, N. O., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1580 · Cited by 450
Tallini, Y. N., Ohkura, M., Choi, B.-R., Ji, G., Imoto, K., Doran, R., Lee, J., Plan, P., Wilson, J., Xin, H.-B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509378103 · Cited by 439
Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells
Monzel, A. S., Smits, L. M., Hemmer, K., Hachi, S., Moreno, E. L., van Wuellen, T., Jarazo, J., Walter, J., Brüggemann, I., Boussaad, I., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.010 · Cited by 435
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Green fluorescent protein‐based halide indicators with improved chloride and iodide affinities
Galietta, L. J. V., Haggie, P. M., & Verkman, A. S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02561-3 · Cited by 371
Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application
Liang, G., & Zhang, Y. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.07.001 · Cited by 369
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Zhang, R.-R., Koike, H., Kimura, M., Yoshizawa, E., Enomura, M., Koike, N., Sekine, K., & Taniguchi, H. (2014) · Nature Protocols · doi:10.1038/nprot.2014.020 · Cited by 367
Biomimetic tissues on a chip for drug discovery
Ghaemmaghami, A. M., Hancock, M. J., Harrington, H., Kaji, H., & Khademhosseini, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.029 · Cited by 359
A Review of the Methods for Human iPSC Derivation
Malik, N., & Rao, M. S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-348-0_3 · Cited by 354
Kidney-on-a-Chip technology for drug-induced nephrotoxicity screening
Wilmer, M. J., Ng, C. P., Lanz, H. L., Vulto, P., Suter-Dick, L., & Masereeuw, R. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.11.001 · Cited by 354
Drexler, H. G., & Uphoff, C. C. (2002) · Cytotechnology · doi:10.1023/a:1022913015916 · Cited by 340
Microfluidic 3D Cell Culture: Potential Application For Tissue-Based Bioassays
Li, X. (., Valadez, A. V., Zuo, P., & Nie, Z. (2012) · Bioanalysis · doi:10.4155/bio.12.133 · Cited by 319
Goldberg, I. G., Allan, C., Burel, J.-M., Creager, D., Falconi, A., Hochheiser, H., Johnston, J., Mellen, J., Sorger, P. K., & Swedlow, J. R. (2005) · Genome Biology · doi:10.1186/gb-2005-6-5-r47 · Cited by 315
Manipulating the mammalian genome by homologous recombination
Vasquez, K. M., Marburger, K., Intody, Z., & Wilson, J. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111009698 · Cited by 303
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
Progress in understanding reprogramming to the induced pluripotent state
Plath, K., & Lowry, W. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2955 · Cited by 289
Ethical issues in stem cell research and therapy
King, N. M., & Perrin, J. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt474 · Cited by 267
Current status of pluripotent stem cells: moving the first therapies to the clinic
Kimbrel, E. A., & Lanza, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4738 · Cited by 261
Kyttälä, A., Moraghebi, R., Valensisi, C., Kettunen, J., Andrus, C., Pasumarthy, K. K., Nakanishi, M., Nishimura, K., Ohtaka, M., Weltner, J., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.12.009 · Cited by 257
Pamies, D. (2017) · ALTEX · doi:10.14573/altex.1609122 · Cited by 250
Self-citationStable genetic modification of human embryonic stem cells by lentiviral vectors
Gropp, M., Itsykson, P., Singer, O., Ben-Hur, T., Reinhartz, E., Galun, E., & Reubinoff, B. E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00047-3 · Cited by 247
3D bioprinting and its in vivo applications
Hong, N., Yang, G., Lee, J., & Kim, G. (2018) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33826 · Cited by 243
Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective
Liang, G., & Zhang, Y. (2013) · Cell Research · doi:10.1038/cr.2012.175 · Cited by 224
Maschmeyer, I., Hasenberg, T., Jaenicke, A., Lindner, M., Lorenz, A. K., Zech, J., Garbe, L.-A., Sonntag, F., Hayden, P., Ayehunie, S., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.002 · Cited by 218
Chang, C.-W., Lai, Y.-S., Pawlik, K. M., Liu, K., Sun, C.-W., Li, C., Schoeb, T. R., & Townes, T. M. (2009) · Stem Cells · doi:10.1002/stem.39 · Cited by 217
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Alépée, N. (2014) · ALTEX · doi:10.14573/altex.1406111 · Cited by 217
Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges
Brazma, A. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.57 · Cited by 205
Yoon No, D., Lee, K.-H., Lee, J., & Lee, S.-H. (2015) · Lab on a Chip · doi:10.1039/c5lc00611b · Cited by 205
Three-dimensional tissue cultures: current trends and beyond
Page, H., Flood, P., & Reynaud, E. G. (2013) · Cell and Tissue Research · doi:10.1007/s00441-012-1441-5 · Cited by 185
West, P. R., Weir, A. M., Smith, A. M., Donley, E. L. R., & Cezar, G. G. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.007 · Cited by 185
Templin, C., Zweigerdt, R., Schwanke, K., Olmer, R., Ghadri, J.-R., Emmert, M. Y., Müller, E., Küest, S. M., Cohrs, S., Schibli, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.087684 · Cited by 181
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Scott, C. W., Peters, M. F., & Dragan, Y. P. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.020 · Cited by 171
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
Self-citationMicrofluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering
Perestrelo, A., Águas, A., Rainer, A., & Forte, G. (2015) · Sensors · doi:10.3390/s151229848 · Cited by 149
Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis
Kilic, O., Pamies, D., Lavell, E., Schiapparelli, P., Feng, Y., Hartung, T., Bal-Price, A., Hogberg, H. T., Quinones-Hinojosa, A., Guerrero-Cazares, H., et al. (2016) · Lab on a Chip · doi:10.1039/c6lc00946h · Cited by 144
Self-citationMoreno, E. L., Hachi, S., Hemmer, K., Trietsch, S. J., Baumuratov, A. S., Hankemeier, T., Vulto, P., Schwamborn, J. C., & Fleming, R. M. T. (2015) · Lab on a Chip · doi:10.1039/c5lc00180c · Cited by 144
Ye, F., Chen, C., Qin, J., Liu, J., & Zheng, C. (2015) · The FASEB Journal · doi:10.1096/fj.14-266718 · Cited by 144
Complex Tissue and Disease Modeling using hiPSCs
Passier, R., Orlova, V., & Mummery, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.011 · Cited by 142
Burrows, C. K., Banovich, N. E., Pavlovic, B. J., Patterson, K., Gallego Romero, I., Pritchard, J. K., & Gilad, Y. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005793 · Cited by 131
Tsaioun, K. (2016) · ALTEX · doi:10.14573/altex.1610101 · Cited by 131
21st Century Cell Culture for 21st Century Toxicology
Pamies, D., & Hartung, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00269 · Cited by 118
Self-citationStem Cell Culture and Differentiation in Microfluidic Devices Toward Organ-on-a-Chip
Zhang, J., Wei, X., Zeng, R., Xu, F., & Li, X. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0091 · Cited by 115
Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28994 · Cited by 114
Andrews, P., Baker, D., Benvinisty, N., Miranda, B., Bruce, K., Br…#x00FC;stle, O., Choi, M., Choi, Y.-M., Crook, J., de Sousa, P., et al. (2015) · Regenerative Medicine · doi:10.2217/rme.14.93 · Cited by 113
Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors
Pettersen, E. O., Larsen, L. H., Ramsing, N. B., & Ebbesen, P. (2005) · Cell Proliferation · doi:10.1111/j.1365-2184.2005.00345.x · Cited by 110
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Roth, A. B., & Singer, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.005 · Cited by 105
Reconsidering pluripotency tests: Do we still need teratoma assays?
Buta, C., David, R., Dressel, R., Emgård, M., Fuchs, C., Gross, U., Healy, L., Hescheler, J., Kolar, R., Martin, U., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.03.001 · Cited by 101
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Howden, S. E., Maufort, J. P., Duffin, B. M., Elefanty, A. G., Stanley, E. G., & Thomson, J. A. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.009 · Cited by 101
Perspectives on In Vitro to In Vivo Extrapolations
Härtung, T. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0026 · Cited by 100
“The future of in vitro toxicology”
Jennings, P. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.08.011 · Cited by 100
Food for thought ... on cell culture
Härtung, T. (2007) · ALTEX · doi:10.14573/altex.2007.3.143 · Cited by 98
van Vliet, E. (2011) · ALTEX · doi:10.14573/altex.2011.1.017 · Cited by 94
Rempel, E., Hoelting, L., Waldmann, T., Balmer, N. V., Schildknecht, S., Grinberg, M., Das Gaspar, J. A., Shinde, V., Stöber, R., Marchan, R., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1573-y · Cited by 93
Three-dimensional perfused cell culture
Li, Z., & Cui, Z. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.006 · Cited by 92
Engineered Liver Platforms for Different Phases of Drug Development
Ware, B. R., & Khetani, S. R. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.001 · Cited by 90
Organs-on-chips: research and commercial perspectives
Balijepalli, A., & Sivaramakrishan, V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.009 · Cited by 89
Nucleofection of Human Embryonic Stem Cells
Siemen, H., Nix, M., Endl, E., Koch, P., Itskovitz-Eldor, J., & Brüstle, O. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.378 · Cited by 88
Epidermal morphogenesis during progressive in vitro 3 D reconstruction at the air–liquid interface
Frankart, A., Malaisse, J., De Vuyst, E., Minner, F., de Rouvroit, C. L., & Poumay, Y. (2012) · Experimental Dermatology · doi:10.1111/exd.12020 · Cited by 87
Detection of contaminants in cell cultures, sera and trypsin
Pinheiro de Oliveira, T. F., Fonseca, A. A., Camargos, M. F., de Oliveira, A. M., Pinto Cottorello, A. C., Souza, A. D. R., de Almeida, I. G., & Heinemann, M. B. (2013) · Biologicals · doi:10.1016/j.biologicals.2013.08.005 · Cited by 85
What if stem cells turn into embryos in a dish?
Pera, M. F., de Wert, G. M. W. R., Dondorp, W., Lovell-Badge, R. H., Mummery, C. L., Munsie, M., & Tam, P. (2015) · Nature Methods · doi:10.1038/nmeth.3586 · Cited by 85
Verkman, A., Lukacs, G., & Galietta, L. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585148 · Cited by 84
Bhushan, A., Senutovitch, N., Bale, S. S., McCarty, W. J., Hegde, M., Jindal, R., Golberg, I., Berk Usta, O., Yarmush, M. L., Vernetti, L., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt377 · Cited by 83
Toward a 3D model of human brain development for studying gene/environment interactions
Hogberg, H. T., Bressler, J., Christian, K. M., Harris, G., Makri, G., O'Driscoll, C., Pamies, D., Smirnova, L., Wen, Z., & Hartung, T. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt365 · Cited by 76
Self-citationA High-Throughput Screen for Teratogens Using Human Pluripotent Stem Cells
Kameoka, S., Babiarz, J., Kolaja, K. L., & Chiao, E. T. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft239 · Cited by 75
Targeted homologous recombination in mammalian cells
Waldman, A. S. (1992) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(92)90064-w · Cited by 67
Mix-ups and mycoplasma: the enemies within
Drexler, H. G., Uphoff, C. C., Dirks, W. G., & MacLeod, R. A. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00136-9 · Cited by 66
Ackermann, M., Lachmann, N., Hartung, S., Eggenschwiler, R., Pfaff, N., Happle, C., Mucci, A., Göhring, G., Niemann, H., Hansen, G., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.024 · Cited by 66
Gruh, I., Wunderlich, S., Winkler, M. E., Schwanke, K., Heinke, J., Blömer, U., Ruhparwar, A., Rohde, B., Li, R., Haverich, A., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1122 · Cited by 64
hPSCreg—the human pluripotent stem cell registry
Seltmann, S., Lekschas, F., Müller, R., Stachelscheid, H., Bittner, M.-S., Zhang, W., Kidane, L., Seriola, A., Veiga, A., Stacey, G., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv963 · Cited by 61
(2019) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789813278851_0009 · Cited by 61
Current approaches and future role of high content imaging in safety sciences and drug discovery
van Vliet, E. (2014) · ALTEX · doi:10.14573/altex.1405271 · Cited by 56
Benabdellah, K., Cobo, M., Muñoz, P., Toscano, M. G., & Martín, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023734 · Cited by 55
Kim, J.-H., Kurtz, A., Yuan, B.-Z., Zeng, F., Lomax, G., Loring, J. F., Crook, J., Ju, J. H., Clarke, L., Inamdar, M. S., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0144 · Cited by 55
Good cell culture practices & in vitro toxicology
Eskes, C., Boström, A.-C., Bowe, G., Coecke, S., Hartung, T., Hendriks, G., Pamies, D., Piton, A., & Rovida, C. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.04.022 · Cited by 52
Self-citationCooper-Hannan, R., Harbell, J. W., Coecke, S., Balls, M., Bowe, G., Červinka, M., Clothier, R., Hermann, F., Klahm, L. K., de Lange, J., et al. (1999) · Alternatives to Laboratory Animals · doi:10.1177/026119299902700410 · Cited by 52
Stem Cells and Stem Cell-derived Tissues and Their Use in Safety Assessment
Kolaja, K. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.481028 · Cited by 38
Soares, F. A. C., Sheldon, M., Rao, M., Mummery, C., & Vallier, L. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.006 · Cited by 37
Merkert, S., Wunderlich, S., Bednarski, C., Beier, J., Haase, A., Dreyer, A.-K., Schwanke, K., Meyer, J., Göhring, G., Cathomen, T., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.12.003 · Cited by 36
Stable transgene expression in human embryonic stem cells after simple chemical transfection
Liu, J., Jones, K. L., Sümer, H., & Verma, P. J. (2008) · Molecular Reproduction and Development · doi:10.1002/mrd.20983 · Cited by 36
Impression 3D en médecine régénératrice et ingénierie tissulaire
Fricain, J., Olivera, H. D., Devillard, R., Kalisky, J., Rémy, M., Kériquel, V., Nihouannen, D. L., Grémare, A., Gudurić, V., Plaud, A., et al. (2017) · médecine/sciences · doi:10.1051/medsci/20173301009 · Cited by 36
Stem cell research policies around the world.
Dhar, D., & Ho, J. H.-E. (2009) · PubMed Central · Cited by 35
Zhang, C., & van Noort, D. (2011) · Topics in current chemistry · doi:10.1007/128_2011_147 · Cited by 34
3D — A new dimension of in vitro research
Hartung, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.003 · Cited by 34
First proposal of minimum information about a cellular assay for regenerative medicine
Sakurai, K., Kurtz, A., Stacey, G., Sheldon, M., & Fujibuchi, W. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0393 · Cited by 31
Returning Results in Biobank Research: Global Trends and Solutions
Clercq, E. D., Kaye, J. S., Wolf, S. M., Koenig, B. A., & Elger, B. S. (2017) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2016.0394 · Cited by 30
Merkert, S., & Martin, U. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.027 · Cited by 28
Current Developments in Cell Culture Technology
Stacey, G. N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3055-1_1 · Cited by 27
Safety in Cell and Tissue Culture
Stacey, G., Doyle, A., & Hambleton, P. (1998) · Springer eBooks · doi:10.1007/978-94-011-4916-7 · Cited by 25
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing
Stacey, G. N., Coecke, S., Price, A., Healy, L. E., Jennings, P., Wilmes, A., Pinset, C., Ingelman‐Sundberg, M., Louisse, J., Haupt, S., et al. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-33826-2_11 · Cited by 24
Glossary of Reference Terms for Alternative Test Methods and their Validation
Ferrario, D. (2008) · ALTEX · doi:10.14573/altex.1403311 · Cited by 24
Trends in Cell Culture Technology
Marx, U. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3055-1_3 · Cited by 19
First evaluation of the European hESCreg
Borstlap, J., Stacey, G. N., Kurtz, A., Elstner, A., Damaschun, A., Arán, B., & Veiga, A. (2008) · Nature Biotechnology · doi:10.1038/nbt0808-859 · Cited by 17
Validation of Bioreactor and Human-on-a-Chip Devices for Chemical Safety Assessment
Rebelo, S. P., Dehne, E., Brito, C., Horland, R., Alves, P. M., & Marx, U. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-33826-2_12 · Cited by 12
European stem cell research in legal shackles
Nielen, M. G., de Vries, S., & Geijsen, N. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.249 · Cited by 11
Glossary of Reference Terms for Alternative Test Methods and their Validation
Ferrario, D. (2014) · ALTEX · doi:10.14573/altex.140331 · Cited by 8
Jennings, P., Aschauer, L., Wilmes, A., & Gstraunthaler, G. J. A. (2014) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-0521-8_4 · Cited by 4
Ethical Issues in the Production of Human Cell Lines and Stem Cell Lines
Balls, M. (2012) · Alternatives to Laboratory Animals · doi:10.1177/026119291204000110 · Cited by 2
Do we need an ethics of self-organizing tissue?
(2015) · Nature Methods · doi:10.1038/nmeth.3618 · Cited by 2
Research works printed but not linked: 1
- altex1406111 · doi:10.14573/altex1406111 · Paper page
Cited by
Evidence-based Guidelines for Controlling pH in Mammalian Live-Cell Culture Systems
Michl, J., Park, K. C., & Swietach, P. (2019) · Communications Biology · doi:10.1038/s42003-019-0393-7 · Cited by 267
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“…form of workshops and supporting guidance documents, such as the OECD Guidance Document (GD) on Good In Vitro Method Practices (OECD, 2018), a recommendation on reporting standards (Hartung et al., 2019) and a Good Cell Culture Practice (GCCP) document for iPSC and MPS (Pamies et al., 2017, 2018).”
BackgroundIn Vitro research Reproducibility: Keeping up High Standards
Hirsch, C., & Schildknecht, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01484 · Cited by 161
Escher, S. E., Kamp, H., Bennekou, S. H., Bitsch, A., Fisher, C., Graepel, R., Hengstler, J. G., Herzler, M., Knight, D. J., Leist, M., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02591-7 · Cited by 166
Metadata
- Authors
- Pamies, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pamies, David
- ORCID
- Pamies, David
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 3
- Pages
- 353-378
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2799414163
- Cited by
- 127
- References
- 140
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 26 · 2019: 15 · 2018: 4
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- University of Twente Research Information (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Joint Research Centre (European Commission) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Horizon 2020 Framework Programme (EU‐H2020, 681002)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- replication crisis, induced pluripotent stem cells, organoids, organ-on-a-chip, primary human cells, cell banks, high-content imaging, high-throughput measurement
- MeSH terms
- Animals, Animal Testing Alternatives, Education, Germany, Humans, Organoids, Quality Control, Guidelines as Topic, Cell Culture Techniques, Pluripotent Stem Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



